
Captured during the 46th annual conference, the UCLA State-of-the-Art Urology online CME course explores the most challenging management problems facing today’s practicing urologist. Distinguished faculty present the latest information, current therapies and expert techniques through 31 insightful lectures and nine panel discussions. Key topic areas include:
Evaluation and Treatment of Mixed Urinary Incontinence in Women 2021
Victor W. Nitti, MD
Tips on 3rd Line Therapies for Overactive Bladder – Videos Included
Kathleen C. Kobashi, MD, FACS
Evaluation and Management of Recurrent UTIs in Women
Kathleen C. Kobashi, MD, FACS
Value of Genetic Testing and Next Generation Sequencing in Diagnosis of UTI
A. Lenore Ackerman, MD, PhD
Panel Discussion: Voiding Dysfunction and UTIs in Women
Audience Questions – Case Presentations
Moderator: Dr. Ja-Hong Kim
Panel: Drs. Ackerman, Baxter, Kobashi, and Nitti
Management of Urethral Stricture Disease in 2021: Dilation, Incision, Reconstruction
Kurt A. McCammon, MD
Underactive Bladder and Bladder Outlet Obstruction in Men: Is Surgery Indicated?
Victor W. Nitti, MD
Are Male Slings a Good Option for Mild and Moderate Stress Incontinence in Men?
Kurt A. McCammon, MD
Panel Discussion: Male Voiding Dysfunction
Audience Questions – Case Presentations
Moderator: Dr. Victor W. Nitti
Panel: Drs. Baxter, Kim, Kobashi, and McCammon
Metabolic Evaluation and Medical Management of Urolithiasis: A Simplified Approach (Stone Tree)
Ralph V. Clayman, MD
Antibiotic Use: Managing Pre and Post-Op Infections in Patients Undergoing Endoscopic Surgery
Matthew Dunn, MD
Death of the PCNL – Increasing Utilization of Ureteroscopy Now and in the Future
Ralph V. Clayman, MD
Ureteral Stents – A Love/Hate Relationship
Kymora Scotland, MD, PhD
Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Clayman and Scotland
Rehab of the Penis Post-Prostatectomy – The Hopkins Experience
Arthur L. Burnett, MD, MBA
How and Why to Set Up a Men’s Health Clinic
Jesse N. Mills, MD
Medical and Surgical Approaches to Priapism
Arthur L. Burnett, MD, MBA
Anorgasmia: What, Why, and How to Treat
Sriram Eleswarapu, MD, PhD
Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Burnett, Eleswarapu, and Mills
Single Port Robotic Surgery – Does This Advance Our Field?
Arnold I. Chin, MD, PhD
Robotic Radical Prostatectomy – Techniques for Optimizing Continence, Potency, and Negative Margins
Robert E. Reiter, MD, MBA
10 Debunked Myths About Prostate Cancer
Scott Eggener, MD
Improving the Quality of Decision Making in Prostate Cancer Using Shared Decision Making
Christopher S. Saigal, MD, MPH
Personalizing Adjuvant vs. Early Salvage Radiotherapy
Daniel E. Spratt, MD
Focal Therapy for Prostate Cancer – State of the Art
Scott Eggener, MD
Active Surveillance in 2021: Update on Intensity of Follow Up and Inclusion of 3+4 Disease
Leonard S. Marks, MD
Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Reiter, Saigal, and Spratt
Personalizing Hormone Therapy with Radiation Therapy Role for Biomarkers
Daniel E. Spratt, MD
Management of Oligometastatic Disease in the World of PSMA Imaging
Robert E. Reiter, MD, MBA
Update on Therapy for Advanced Prostate Cancer Integrating Genetic Testing
Matthew Rettig, MD
Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Rettig, Reiter, and Spratt
New Advances in Bladder Cancer in 2021
Karim Chamie, MD, MSHS
Updates for Non-Muscle Invasive Bladder Cancer During BCG Shortage
Sam S. Chang, MD, MBA
Advances in Upper Tract Urothelial Cancer
Sam S. Chang, MD, MBA
Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin Panel: Drs. Chamie, Chang, Chin, Drakaki, and Kishan
Everything a Urologist Needs to Know About Testis Cancer
Scott Eggener, MD
Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Stanley K. Frencher, Jr.
Panel: Drs. Eggener, Drakaki, and Litwin
Role for Elective Radical Nephrectomy for T1B/T2A Renal Tumors
Brian Shuch, MD
Management Considerations for Bilateral/Multifocal Renal Tumors
Brian Shuch, MD
Panel Discussion and Case Presentations
Moderator: Dr. Brian Shuch
Panel: Drs. Chamie, Liu, Padia, Pantuck, and Ye
Patrick C. Walsh Distinguished Professor of Urology, Oncology
The Brady Urological Institute
Department of Urology
Johns Hopkins Medical Institutions
Baltimore, MD
Patricia and Rodes Hart Professor of Urologic Surgery
Vanderbilt University Medical Center
Chief Surgical Officer
Vanderbilt Ingram Cancer Center
Nashville, TN
Distinguished Professor/Endowed Chair in Endourology
Dean – emeritus
University of California, Irvine
Department of Urology
Orange, CA
Professor of Surgery
University of Chicago
Chicago, IL
Head, Section of Urology and Renal Transplantation
Virginia Mason Medical Center
Seattle, WA
Devine Chair in Genitourinary Reconstructive Surgery
Chairman and Program Director
Professor Department of Urology
Eastern Virginia Medical School
Norfolk, VA
Professor of Radiation Oncology
Laurie Snow Endowed Research Professor
Associate Chair, Clinical Research
Chair, Genitourinary Clinical Research, Rogel Cancer Center
University of Michigan
Ann Arbor, MI
Professor and Chair
Department of Urology
Professor of Health Policy and Management
School of Public Health
Assistant Professor of Medicine and Urology
Director - Genitourinary Medical Oncology Program
Co-Director of Research, GU Trials Program
Division of Hematology/Oncology and Institute of Urologic Oncology
Assistant Professor
Chief of Genitourinary Oncology Service
Vice Chair of Clinical and Translational Research
Department of Radiation Oncology
Division of Hematology-Oncology
Department of Medicine
Institute of Urologic Oncology
Department of Urology
Professor
Interventional Radiology
Director, IR at UCLA Santa Monica
Professor of Medicine and Urology
Medical Director, Prostate Cancer Program
Institute of Urologic Oncology
Associate Director, Hematology-Oncology Fellowship Program
David Geffen School of Medicine at UCLA
Chief, Division of Hematology-Oncology
VA Greater Los Angeles – West Los Angeles
Chief of Genitourinary Pathology
Associate Professor, Department of Pathology
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this enduring activity for a maximum of 16 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Original Release: April 16, 2021
Date Credits Expire: April 15, 2024
Estimated Time to Complete: 16 hours
CME credit is awarded upon successful completion of a course evaluation and post-test.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the sponsor adequately manage all identified potential conflicts of interest prior to the program. We, at UCLA fully endorse the letter and spirit of these concepts.
Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.
At the completion of this program, participants should be better able to:
This course explores the most challenging management problems facing the practicing urologist.
Provider: David Geffen School of Medicine at UCLA
Course Chair:
William J. Aronson, MD
Course Co-Chairs:
Craig Canfield, MD
Karim Chamie, MD, MSHS
Credits: Earn a maximum of 16.00 AMA PRA Category 1 Credits™
SKU: URV455E0